Lipopolysaccharide-stimulated MAPK and Hepatocyte growth factor (HGF) signaling were activated in the newly differentiated hepatocytes (GFP+R) but not in the tumor-reverted hepatocytes (RFP+R), indicating that these activities may be required in nascent hepatocytes. The gene discussed is HGF; the disease is neoplasm.